GE Healthcare Life Sciences
Biacore Life Sciences
You are here: Biacore Life Sciences > LMW Drug discovery
printer friendly
Confidently select the best candidates
back
High quality compound screening and characterization increases productivity and cost-efficiency:
Facilitates more confident selection of compounds (high information content)
Enables analysis of problem targets with unknown or unstable substrates (direct compound-target binding assays)
Efficiently eliminates false-positives (easy provision of selectivity controls)
Low consumption of target proteins compared to alternative methods
Avoids complications and artifacts associated with labelling (SPR detection)

Label-free compound screening

Label-free compound characterization

more
more

Which system should I choose?

GoodGood
BetterBetter
BestBest

Biacore A100
Unmatched productivity

Identify selective binders using informative panels of target proteins for successful drug discovery

Excellent

Biacore T100
Unmatched performance

Develop assays to characterize target: LMW compound interactions
Characterize protein therapeutics and implement QC methods
21 CFR Part 11 Compliance
Excellent